The long-term goal of this pilot project is to develop a comprehensive research resource to: a) study genetic predispositions and environmental interactions in lung cancer etiology, and b) foster methods for identification of individuals at high risk for lung cancer. Specifically, we propose to develop a family panel data base ascertained through incident cases of lung cancer seen at the Johns Hopkins Hospital. We will characterize index cases with respect to family history and environmental risk factors, including smoking, collected by questionnaire/interview. Blood samples on available family members will be obtained, and a database of accessible family members will be developed for future physiologic, biomarker, and molecular genetic studies by other projects within the SPORE. Within the pilot study, we will use two approaches to analyze the data that we collect: 1) Segregation analysis using regressive logistic models will be performed on the obtained pedigrees to estimate the genetic and environmental contributions to lung cancer risk considering age at onset; and 2) Affected relative pairs from the family panel will be studied to test the hypothesis of concordance of tumor histology (SCLC vs non- SCLC).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA058184-04
Application #
5209192
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Hulbert, Alicia; Jusue-Torres, Ignacio; Stark, Alejandro et al. (2017) Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clin Cancer Res 23:1998-2005
Zhong, Yi; Macgregor-Das, Anne; Saunders, Tyler et al. (2017) Mutant p53 Together with TGF? Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. Clin Cancer Res 23:1607-1620
Chiappinelli, Katherine B; Zahnow, Cynthia A; Ahuja, Nita et al. (2016) Combining Epigenetic and Immunotherapy to Combat Cancer. Cancer Res 76:1683-9
Singh, Anju; Venkannagari, Sreedhar; Oh, Kyu H et al. (2016) Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. ACS Chem Biol 11:3214-3225
Chiappinelli, Katherine B; Strissel, Pamela L; Desrichard, Alexis et al. (2015) Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 162:974-86
Vendetti, Frank P; Topper, Michael; Huang, Peng et al. (2015) Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget 6:56-70
Belinsky, Steven A (2015) Unmasking the lung cancer epigenome. Annu Rev Physiol 77:453-74
Sussan, Thomas E; Gajghate, Sachin; Thimmulappa, Rajesh K et al. (2015) Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 10:e0116861
Hulbert, Alicia; Hooker, Craig M; Keruly, Jeanne C et al. (2014) Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. J Thorac Oncol 9:752-9
Kombairaju, Ponvijay; Kerr, Jaclyn P; Roche, Joseph A et al. (2014) Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle. Front Physiol 5:57

Showing the most recent 10 out of 256 publications